Flu, Human: Clinical Trials

3 trials for Flu, Human, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3

Follow Flu, Human: new trials by email Literature Review of Flu, Human trials Research Report on Flu, Human

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol Plus
Grippol Quadrivalent, Grippol Plus - Influenza, Influenza A
Phase 3CompletedNPO Petrovax8242022-09-212024-04-26
Tolerability, Safety and Immunogenicity Trial of the Flu-M® Inactivated Vaccine in Volunteers Aged 18 to 60 Years
Flu-M [inactivated split influenza vaccine] without preservative, Flu-M [inactivated split influenza vaccine] with preservative - Influenza, Flu, Human
Phase 3CompletedSt. Petersburg Research Institute of Vaccines and Sera6542020-12-072022-04-05
Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Immunosuppressive Conditions *aH5N1:Monovalent H5N1 Influenza Vaccine
Novartis Investigational H5N1 vaccine, Novartis Seasonal Influenza Vaccine - Influenza, Human, Flu, Human
Phase 3CompletedSeqirus5392014-04-012016-05-09

Narrower conditions

Influenza, Human (3)  ·  Influenza in Birds (1)  ·  Orthomyxoviridae Infections (1)

Broader conditions

Infections (3)  ·  RNA Virus Infections (3)  ·  Respiratory Tract Diseases (3)  ·  Respiratory Tract Infections (3)  ·  Virus Diseases (3)  ·  Orthomyxoviridae Infections (2)  ·  Animal Diseases (1)  ·  Bird Diseases (1)

Interventions

Grippol (1)

Sponsors

NPO Petrovax (1)  ·  Seqirus (1)  ·  St. Petersburg Research Institute of Vaccines and Sera (1)

Countries

Russia (2)  ·  Australia (1)  ·  Germany (1)  ·  Italy (1)